Antiverse
Cardiff
About Antiverse
Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2026)
- Website: antiverse.io
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/antiverse-89519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.